Asia Pacific Huntingtons Disease Treatment Market Size & Outlook

The huntingtons disease treatment market in Asia Pacific is expected to reach a projected revenue of US$ 525.8 million by 2030. A compound annual growth rate of 24.4% is expected of Asia Pacific huntingtons disease treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$136.9
Forecast, 2030 (US$M)
$525.8
CAGR, 2025 - 2030
24.4%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific huntingtons disease treatment market, 2018-2030 (US$M)

Asia Pacific huntingtons disease treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific huntingtons disease treatment market highlights

  • The Asia Pacific huntingtons disease treatment market generated a revenue of USD 136.9 million in 2024.
  • The market is expected to grow at a CAGR of 24.4% from 2025 to 2030.
  • In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2024.
  • Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 136.9 million
Market revenue in 2030USD 525.8 million
Growth rate24.4% (CAGR from 2025 to 2030)
Largest segmentSymptomatic treatment
Fastest growing segmentSymptomatic Treatment
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSymptomatic Treatment
Key market players worldwideH. Lundbeck AS Class A, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Hetero, Lupin, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd ADR, Sun Pharmaceutical Industries

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 27.3% of the global huntingtons disease treatment market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 525.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Huntingtons Disease Treatment Market Companies

Name Profile # Employees HQ Website

Asia Pacific huntingtons disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.


Symptomatic treatment was the largest segment with a revenue share of 129% in 2024. Horizon Databook has segmented the Asia Pacific huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.


There is little to no reimbursement in underdeveloped economies. Improving healthcare reimbursement guidelines, presence of larger target population in India & China as compared to other Asian countries, and high unmet needs are among factors expected to provide lucrative growth opportunity to companies in this region.

Rising number of initiatives being undertaken by governments to improve health status of the population is expected to drive market growth during the forecast period. However, the market is competitive, which may hamper market growth in this region.

For instance, in July 2021, Teva Pharmaceutical Industries Ltd. filed a patent lawsuit against Indian generic manufacturers—Lupin Ltd. and Aurobindo Pharma Ltd—to prevent them from releasing generic version of Austedo in the market.

Reasons to subscribe to Asia Pacific huntingtons disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific huntingtons disease treatment market databook

  • Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific huntingtons disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific huntingtons disease treatment market size, by country, 2018-2030 (US$M)

Asia Pacific Huntingtons Disease Treatment Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific huntingtons disease treatment market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online